Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-22

FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HCL — Original Application (Granules India Ltd)

View source ↗

Summary

FDA approved Granules India Ltd's guaifenesin and pseudoephedrine HCl as an Original Application (ANDA) for a generic combination product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guaifenesin and Pseudoephedrine HCl (guaifenesin and pseudoephedrine hydrochloride)

Snippet

ORIG AP for GUAIFENESIN AND PSEUDOEPHEDRINE HCL (GUAIFENESIN AND PSEUDOEPHEDRINE HCL)